[1] |
BERG D D, RUFF C T, JAROLIM P,et al. Performance of the ABC scores for assessing the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in ENGAGE AF-TIMI 48[J]. Circulation,2019,139(6):760-771. DOI:10.1161/CIRCULATIONAHA.118.038312.
|
[2] |
赵庆豪,许海燕,杨跃进,等. 40年来北京地区急性心肌梗死患者人口学特征、危险因素和诱发因素变化分析[J]. 中国循环杂志,2018,33(4):317-321. DOI:10.3969/j.issn.1000-3614.2018.04.002.
|
[3] |
TSENG C H, CHUNG W J, LI C Y,et al. Statins reduce new-onset atrial fibrillation after acute myocardial infarction:a nationwide study[J]. Medicine (Baltimore),2020,99(2):e18517. DOI:10.1097/MD.0000000000018517.
|
[4] |
MAENG M, STEG P G, BHATT D L,et al. Dabigatran dual therapy versus warfarin triple therapy post-PCI in patients with atrial fibrillation and diabetes[J]. JACC Cardiovasc Interv,2019,12(23):2346-2355. DOI:10.1016/j.jcin.2019.07.059.
|
[5] |
MURTAZA G, VIRK H U H, KHALID M,et al. Diabetic cardiomyopathy - A comprehensive updated review[J]. Prog Cardiovasc Dis,2019,62(4):315-326. DOI:10.1016/j.pcad.2019.03.003.
|
[6] |
ZELNIKER T A, BONACA M P, FURTADO R H M,et al. Effect of dapagliflozin on atrial fibrillation in patients with type 2 diabetes mellitus:insights from the DECLARE-TIMI 58 trial[J]. Circulation,2020,141(15):1227-1234. DOI:10.1161/CIRCULATIONAHA.119.044183.
|
[7] |
LING A W, CHAN C C, CHEN S W,et al. The risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors[J]. Cardiovasc Diabetol,2020,19(1):188. DOI:10.1186/s12933-020-01162-w.
|
[8] |
THYGESEN K, ALPERT J S, JAFFE A S,et al. Fourth universal definition of myocardial infarction (2018)[J]. Circulation,2018,138(20):e618-651. DOI:10.1161/CIR.0000000000000617.
|
[9] |
中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J]. 中华内分泌代谢杂志,2021,37(4):311-398. DOI:10.3760/cma.j.cn311282-20210304-00142.
|
[10] |
MOSS T J, CALLAND J F, ENFIELD K B,et al. New-onset atrial fibrillation in the critically ill[J]. Crit Care Med,2017,45(5):790-797. DOI:10.1097/ccm.0000000000002325.
|
[11] |
RUIZ L A, SERRANO L, ESPAÑA P P,et al. New-onset atrial fibrillation in patients with pneumococcal pneumonia. Impact of timing and duration on short- and medium-term mortality[J]. J Infect,2021,82(1):67-75. DOI:10.1016/j.jinf.2020.11.005.
|
[12] |
ARRIGO M, ISHIHARA S, FELIOT E,et al. New-onset atrial fibrillation in critically ill patients and its association with mortality:a report from the FROG-ICU study[J]. Int J Cardiol,2018,266:95-99. DOI:10.1016/j.ijcard.2018.03.051.
|
[13] |
KIM Y G, HAN K D, CHOI J I,et al. The impact of body weight and diabetes on new-onset atrial fibrillation:a nationwide population based study[J]. Cardiovasc Diabetol,2019,18(1):128. DOI:10.1186/s12933-019-0932-z.
|
[14] |
PACKER M. Disease-treatment interactions in the management of patients with obesity and diabetes who have atrial fibrillation:the potential mediating influence of epicardial adipose tissue[J]. Cardiovasc Diabetol,2019,18(1):121. DOI:10.1186/s12933-019-0927-9.
|
[15] |
CRUZ-HERRANZ A, FUENTES B, MARTÍNEZ-SÁNCHEZ P,et al. Is diabetes an independent risk factor for in-hospital complications after a stroke? [J]. J Diabetes,2015,7(5):657-663. DOI:10.1111/1753-0407.12222.
|
[16] |
赵丽,赵昕,荆全民,等. 急性心肌梗死合并室间隔穿孔糖尿病患者临床预后[J]. 临床军医杂志,2019,47(10):1087-1090. DOI:10.16680/j.1671-3826.2019.10.25.
|
[17] |
LEE J H, KIM S H, LEE W,et al. New-onset paroxysmal atrial fibrillation in acute myocardial infarction:increased risk of stroke[J]. BMJ Open,2020,10(9):e039600. DOI:10.1136/bmjopen-2020-039600.
|
[18] |
WATANABE M, YOKOSHIKI H, MITSUYAMA H,et al. Conduction and refractory disorders in the diabetic atrium[J]. Am J Physiol Heart Circ Physiol,2012,303(1):H86-95. DOI:10.1152/ajpheart.00010.2012.
|
[19] |
娄逸,钱菊英,陈章炜,等. 2型糖尿病对急性STEMI患者经皮冠状动脉介入治疗后炎症反应及远期心肌重构的影响[J]. 中国临床医学,2019,26(3):398-405. DOI:10.12025/j.issn.1008-6358.2019.20190551.
|
[20] |
OTAKE H, SUZUKI H, HONDA T,et al. Influences of autonomic nervous system on atrial arrhythmogenic substrates and the incidence of atrial fibrillation in diabetic heart[J]. Int Heart J,2009,50(5):627-641. DOI:10.1536/ihj.50.627.
|
[21] |
CHANG S H, WU L S, CHIOU M J,et al. Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus:a population-based dynamic cohort and in vitro studies[J]. Cardiovasc Diabetol,2014,13:123. DOI:10.1186/s12933-014-0123-x.
|